News Takeda begins new R&D link-up with Molecular Templates Takeda is increasing its R&D investment in oncology with a collaboration with Texas biotech Molecular Templates.
News BMS snaps up cancer biotech IFM in $2.3bn deal BMS will gain rights to preclinical cancer immunotherapy drugs.
News NICE recommends Celgene pancreatic cancer drug Abraxane finally gets NHS funding following price cut.
News Scottish firm gets EU funding for 'off the shelf' cancer cel... First patients could be treated in 2019.
News Ex-Google exec Jeff Huber steps down as GRAIL CEO Huber takes on new role as vice chairman of Board of Directors.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
